FHIT Monoclonal antibody
FHIT Monoclonal Antibody for ELISA
Host / Isotype
Mouse / IgG1
Reactivity
human
Applications
WB, IHC, ELISA
Conjugate
Unconjugated
CloneNo.
4D6G1
Cat no : 66086-1-Ig
Synonyms
Validation Data Gallery
Published Applications
WB | See 1 publications below |
IHC | See 2 publications below |
Product Information
The immunogen of 66086-1-Ig is FHIT Fusion Protein expressed in E. coli.
Tested Reactivity | human |
Cited Reactivity | human |
Host / Isotype | Mouse / IgG1 |
Class | Monoclonal |
Type | Antibody |
Immunogen | FHIT fusion protein Ag14471 |
Full Name | fragile histidine triad gene |
Calculated Molecular Weight | 147 aa, 17 kDa |
Observed Molecular Weight | 17 kDa |
GenBank Accession Number | BC032336 |
Gene Symbol | FHIT |
Gene ID (NCBI) | 2272 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein G purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
The candidate tumor suppressor gene, FHIT(Fragile histidine triad protein), encompasses the common human chromosomal fragile site at 3p14.2, the hereditary renal cancer translocation breakpoint, and cancer cell homozygous deletions. Fhit hydrolyzes dinucleotide 5',5'''-P1,P3-triphosphate in vitro and mutation of a central histidine abolishes hydrolase activity(PMID:9391102). FHIT has a major role in regulating beta-catenin-mediated gene transcription.
Protocols
Product Specific Protocols | |
---|---|
WB protocol for FHIT antibody 66086-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Cancer Biomark FHIT and C-MYC expression in cervical histology and cytology as biomarkers for detecting high-grade intraepithelial neoplasia in human papillomavirus-positive women. | ||
Int J Clin Exp Pathol Upregulation of FHIT gene expression in endometrial carcinoma by RNA activation. |